Correction: Update on VTE.

Area of Science:

• Pharmacology
• Internal Medicine
• Cardiology

Background:

• Venous thromboembolism (VTE) management guidelines are crucial for patient care.
• Accurate dosing of anticoagulants is essential for efficacy and safety.
• Previous publications may contain errors requiring correction.

Purpose of the Study:

• To correct erroneous dosing information in a previously published article on VTE management.
• To provide accurate guidance on anticoagulant dose reduction based on specific patient criteria.

Main Methods:

• Review and correction of specific sentences within a published article.
• Identification of criteria for anticoagulant dose adjustment, including age, body weight, and renal function.

Main Results:

• Corrected dosing for a specific anticoagulant: 2.5 mg twice daily for patients meeting at least two criteria (age ≥ 80, weight ≤ 60 kg, or serum creatinine ≥ 1.5 mg/dL).
• Corrected dosing for Edoxaban: 30 mg once daily if creatinine clearance (CrCL) is 30–50 mL/min, body weight is ≤ 60 kg, or with specific drug interactions.

Conclusions:

• Accurate VTE medication dosing is critical.
• Dose adjustments for anticoagulants must account for patient-specific factors like age, weight, and renal function.
• Ensuring the accuracy of published medical information is vital for clinical practice.